Trial Details

RECRUITING
Basic Information
Clinical ID c451
Identifier NCT06599658
Trial Title COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions COVID 19|Influenza|Rheumatoid Arthritis (RA)|Systemic Lupus Erthematosus|Inflammatory Bowel Disease|Solid Organ Transplant Recipients|Immunocompromised Host|People Living With HIV
Interventions BIOLOGICAL: Inactivated influenza vaccine (IIV) at baseline|BIOLOGICAL: COVID-19 Vaccines at a 3-month interval|BIOLOGICAL: Inactivated influenza vaccine at Month 1|BIOLOGICAL: COVID-19 Vaccines at a 6-month interval
Participant Information
Sponsor McGill University Health Centre/Research Institute of the McGill University Health Centre
City Quebec
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2024-11-20
Primary Completion Date 2027-03-31
Completion Date 2027-03-31